位置:首页 > 蛋白库 > FANCE_HUMAN
FANCE_HUMAN
ID   FANCE_HUMAN             Reviewed;         536 AA.
AC   Q9HB96; A8K907; Q4ZGH2;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=Fanconi anemia group E protein;
DE            Short=Protein FACE;
GN   Name=FANCE; Synonyms=FACE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INVOLVEMENT IN FANCE.
RX   PubMed=11001585; DOI=10.1016/s0002-9297(07)62959-0;
RA   de Winter J.P., Leveille F., van Berkel C.G.M., Rooimans M.A.,
RA   van der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N.,
RA   Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K.,
RA   Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., Joenje H.;
RT   "Isolation of a cDNA representing the Fanconi anemia complementation group
RT   E gene.";
RL   Am. J. Hum. Genet. 67:1306-1308(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-89; LEU-204; ARG-340;
RP   GLN-343 AND THR-502.
RG   NIEHS SNPs program;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12093742; DOI=10.1093/emboj/cdf355;
RA   Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M.E.,
RA   de Winter J.P., Joenje H., Gergely F., Patel K.J.;
RT   "FANCE: the link between Fanconi anaemia complex assembly and activity.";
RL   EMBO J. 21:3414-3423(2002).
RN   [8]
RP   INTERACTION WITH FANCC AND FANCD2.
RX   PubMed=12649160; DOI=10.1182/blood-2002-11-3517;
RA   Gordon S.M., Buchwald M.;
RT   "Fanconi anemia protein complex: mapping protein interactions in the yeast
RT   2- and 3-hybrid systems.";
RL   Blood 102:136-141(2003).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCC; FANCF; FANCG AND FANCL.
RX   PubMed=12724401; DOI=10.1128/mcb.23.10.3417-3426.2003;
RA   Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H.,
RA   Hoatlin M.E., Wang W.;
RT   "A multiprotein nuclear complex connects Fanconi anemia and Bloom
RT   syndrome.";
RL   Mol. Cell. Biol. 23:3417-3426(2003).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCF; FANCG AND
RP   FANCL.
RX   PubMed=15502827; DOI=10.1038/ng1458;
RA   Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C.,
RA   Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W.,
RA   Joenje H.;
RT   "X-linked inheritance of Fanconi anemia complementation group B.";
RL   Nat. Genet. 36:1219-1224(2004).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCF; FANCG; FANCL
RP   AND FANCM.
RX   PubMed=16116422; DOI=10.1038/ng1626;
RA   Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P.,
RA   Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H.,
RA   de Winter J.P., Wang W.;
RT   "A human ortholog of archaeal DNA repair protein Hef is defective in
RT   Fanconi anemia complementation group M.";
RL   Nat. Genet. 37:958-963(2005).
RN   [12]
RP   FUNCTION IN DNA REPAIR, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-346
RP   AND SER-374, MUTAGENESIS OF THR-346 AND SER-374, AND UBIQUITINATION.
RX   PubMed=17296736; DOI=10.1128/mcb.02357-06;
RA   Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., D'Andrea A.D.;
RT   "Chk1-mediated phosphorylation of FANCE is required for the Fanconi
RT   anemia/BRCA pathway.";
RL   Mol. Cell. Biol. 27:3098-3108(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   IDENTIFICATION IN THE FA COMPLEX.
RX   PubMed=22266823; DOI=10.1038/nsmb.2222;
RA   Kim H., Yang K., Dejsuphong D., D'Andrea A.D.;
RT   "Regulation of Rev1 by the Fanconi anemia core complex.";
RL   Nat. Struct. Mol. Biol. 19:164-170(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   VARIANT FANCE GLN-184.
RX   PubMed=17924555; DOI=10.1002/humu.20625;
RA   Ameziane N., Errami A., Leveille F., Fontaine C., de Vries Y.,
RA   van Spaendonk R.M., de Winter J.P., Pals G., Joenje H.;
RT   "Genetic subtyping of Fanconi anemia by comprehensive mutation screening.";
RL   Hum. Mutat. 29:159-166(2008).
CC   -!- FUNCTION: As part of the Fanconi anemia (FA) complex functions in DNA
CC       cross-links repair. Required for the nuclear accumulation of FANCC and
CC       provides a critical bridge between the FA complex and FANCD2.
CC       {ECO:0000269|PubMed:12093742, ECO:0000269|PubMed:17296736}.
CC   -!- SUBUNIT: Belongs to the multisubunit FA complex composed of FANCA,
CC       FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is
CC       not found in FA patients. Interacts with FANCC and FANCD2.
CC       {ECO:0000269|PubMed:12649160, ECO:0000269|PubMed:12724401,
CC       ECO:0000269|PubMed:15502827, ECO:0000269|PubMed:16116422,
CC       ECO:0000269|PubMed:22266823}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12093742,
CC       ECO:0000269|PubMed:17296736}.
CC   -!- PTM: Phosphorylated. Phosphorylation by CHEK1 at Thr-346 and Ser-374
CC       regulates its function in DNA cross-links repair.
CC       {ECO:0000269|PubMed:17296736}.
CC   -!- PTM: Ubiquitinated. Phosphorylation by CHEK1 induces polyubiquitination
CC       and degradation. {ECO:0000269|PubMed:17296736}.
CC   -!- DISEASE: Fanconi anemia complementation group E (FANCE) [MIM:600901]: A
CC       disorder affecting all bone marrow elements and resulting in anemia,
CC       leukopenia and thrombopenia. It is associated with cardiac, renal and
CC       limb malformations, dermal pigmentary changes, and a predisposition to
CC       the development of malignancies. At the cellular level it is associated
CC       with hypersensitivity to DNA-damaging agents, chromosomal instability
CC       (increased chromosome breakage) and defective DNA repair.
CC       {ECO:0000269|PubMed:11001585, ECO:0000269|PubMed:17924555}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FANCEID293.html";
CC   -!- WEB RESOURCE: Name=Fanconi Anemia Mutation Database;
CC       URL="https://www2.rockefeller.edu/fanconi/genes/jumpe";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fance/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF265210; AAG16743.1; -; mRNA.
DR   EMBL; DQ020173; AAY26395.1; -; Genomic_DNA.
DR   EMBL; AK292522; BAF85211.1; -; mRNA.
DR   EMBL; AL022721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03830.1; -; Genomic_DNA.
DR   EMBL; BC046359; AAH46359.1; -; mRNA.
DR   CCDS; CCDS4805.1; -.
DR   RefSeq; NP_068741.1; NM_021922.2.
DR   PDB; 2ILR; X-ray; 2.00 A; A=273-536.
DR   PDB; 7KZP; EM; 3.10 A; E=1-536.
DR   PDB; 7KZQ; EM; 4.20 A; E=1-536.
DR   PDB; 7KZR; EM; 4.20 A; E=1-536.
DR   PDB; 7KZS; EM; 4.20 A; E=1-536.
DR   PDB; 7KZT; EM; 4.20 A; E=1-536.
DR   PDB; 7KZV; EM; 4.20 A; E=1-536.
DR   PDBsum; 2ILR; -.
DR   PDBsum; 7KZP; -.
DR   PDBsum; 7KZQ; -.
DR   PDBsum; 7KZR; -.
DR   PDBsum; 7KZS; -.
DR   PDBsum; 7KZT; -.
DR   PDBsum; 7KZV; -.
DR   AlphaFoldDB; Q9HB96; -.
DR   SMR; Q9HB96; -.
DR   BioGRID; 108475; 35.
DR   ComplexPortal; CPX-6263; Fanconi anemia ubiquitin ligase complex.
DR   CORUM; Q9HB96; -.
DR   DIP; DIP-32845N; -.
DR   IntAct; Q9HB96; 13.
DR   MINT; Q9HB96; -.
DR   STRING; 9606.ENSP00000229769; -.
DR   iPTMnet; Q9HB96; -.
DR   PhosphoSitePlus; Q9HB96; -.
DR   BioMuta; FANCE; -.
DR   DMDM; 45476978; -.
DR   EPD; Q9HB96; -.
DR   jPOST; Q9HB96; -.
DR   MassIVE; Q9HB96; -.
DR   MaxQB; Q9HB96; -.
DR   PaxDb; Q9HB96; -.
DR   PeptideAtlas; Q9HB96; -.
DR   PRIDE; Q9HB96; -.
DR   ProteomicsDB; 81510; -.
DR   TopDownProteomics; Q9HB96; -.
DR   Antibodypedia; 4446; 200 antibodies from 30 providers.
DR   DNASU; 2178; -.
DR   Ensembl; ENST00000229769.3; ENSP00000229769.2; ENSG00000112039.5.
DR   GeneID; 2178; -.
DR   KEGG; hsa:2178; -.
DR   MANE-Select; ENST00000229769.3; ENSP00000229769.2; NM_021922.3; NP_068741.1.
DR   UCSC; uc003oko.2; human.
DR   CTD; 2178; -.
DR   DisGeNET; 2178; -.
DR   GeneCards; FANCE; -.
DR   GeneReviews; FANCE; -.
DR   HGNC; HGNC:3586; FANCE.
DR   HPA; ENSG00000112039; Low tissue specificity.
DR   MalaCards; FANCE; -.
DR   MIM; 600901; phenotype.
DR   MIM; 613976; gene.
DR   neXtProt; NX_Q9HB96; -.
DR   OpenTargets; ENSG00000112039; -.
DR   Orphanet; 84; Fanconi anemia.
DR   PharmGKB; PA28000; -.
DR   VEuPathDB; HostDB:ENSG00000112039; -.
DR   eggNOG; ENOG502QQV6; Eukaryota.
DR   GeneTree; ENSGT00390000000705; -.
DR   HOGENOM; CLU_037283_0_0_1; -.
DR   InParanoid; Q9HB96; -.
DR   OMA; PQICQRN; -.
DR   OrthoDB; 575714at2759; -.
DR   PhylomeDB; Q9HB96; -.
DR   TreeFam; TF330720; -.
DR   PathwayCommons; Q9HB96; -.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   SignaLink; Q9HB96; -.
DR   SIGNOR; Q9HB96; -.
DR   BioGRID-ORCS; 2178; 56 hits in 1080 CRISPR screens.
DR   EvolutionaryTrace; Q9HB96; -.
DR   GeneWiki; FANCE; -.
DR   GenomeRNAi; 2178; -.
DR   Pharos; Q9HB96; Tbio.
DR   PRO; PR:Q9HB96; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9HB96; protein.
DR   Bgee; ENSG00000112039; Expressed in buccal mucosa cell and 121 other tissues.
DR   ExpressionAtlas; Q9HB96; baseline and differential.
DR   Genevisible; Q9HB96; HS.
DR   GO; GO:0000785; C:chromatin; IDA:ComplexPortal.
DR   GO; GO:0043240; C:Fanconi anaemia nuclear complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0036297; P:interstrand cross-link repair; IC:ComplexPortal.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:ComplexPortal.
DR   CDD; cd07439; FANCE_c-term; 1.
DR   InterPro; IPR039685; FANCE.
DR   InterPro; IPR021025; Fanconi_anaemia_gr_E_prot_C.
DR   PANTHER; PTHR32094; PTHR32094; 1.
DR   Pfam; PF11510; FA_FANCE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disease variant; DNA damage; DNA repair; Fanconi anemia;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..536
FT                   /note="Fanconi anemia group E protein"
FT                   /id="PRO_0000087187"
FT   REGION          150..371
FT                   /note="Interaction with FANCC"
FT                   /evidence="ECO:0000269|PubMed:12649160"
FT   REGION          171..252
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        181..240
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         346
FT                   /note="Phosphothreonine; by CHEK1"
FT                   /evidence="ECO:0000269|PubMed:17296736"
FT   MOD_RES         374
FT                   /note="Phosphoserine; by CHEK1"
FT                   /evidence="ECO:0000269|PubMed:17296736"
FT   VARIANT         89
FT                   /note="R -> L (in dbSNP:rs45600543)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_023372"
FT   VARIANT         184
FT                   /note="P -> Q (in FANCE; uncertain pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:17924555"
FT                   /id="VAR_038022"
FT   VARIANT         204
FT                   /note="S -> L (in dbSNP:rs7761870)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_023373"
FT   VARIANT         340
FT                   /note="G -> R (in dbSNP:rs45524646)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_023374"
FT   VARIANT         343
FT                   /note="R -> Q (in dbSNP:rs45467798)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_023375"
FT   VARIANT         502
FT                   /note="A -> T (in dbSNP:rs9462088)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_023376"
FT   MUTAGEN         346
FT                   /note="T->A: Non-phosphorylatable by CHEK1, not
FT                   polyubiquitinated and unable to complement the mitomycin C
FT                   hypersensitivity of cells lacking FANCE; when associated
FT                   with A-374."
FT                   /evidence="ECO:0000269|PubMed:17296736"
FT   MUTAGEN         374
FT                   /note="S->A: Non-phosphorylatable by CHEK1, not
FT                   polyubiquitinated and unable to complement the mitomycin C
FT                   hypersensitivity of cells lacking FANCE; when associated
FT                   with A-346."
FT                   /evidence="ECO:0000269|PubMed:17296736"
FT   HELIX           282..299
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           311..314
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           315..318
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           321..331
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           338..350
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           357..374
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           381..393
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           395..408
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           414..425
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           431..443
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           448..458
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           466..477
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           487..499
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           501..503
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           506..516
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   STRAND          518..523
FT                   /evidence="ECO:0007829|PDB:2ILR"
FT   HELIX           524..534
FT                   /evidence="ECO:0007829|PDB:2ILR"
SQ   SEQUENCE   536 AA;  58711 MW;  0E94D8C469C791A5 CRC64;
     MATPDAGLPG AEGVEPAPWA QLEAPARLLL QALQAGPEGA RRGLGVLRAL GSRGWEPFDW
     GRLLEALCRE EPVVQGPDGR LELKPLLLRL PRICQRNLMS LLMAVRPSLP ESGLLSVLQI
     AQQDLAPDPD AWLRALGELL RRDLGVGTSM EGASPLSERC QRQLQSLCRG LGLGGRRLKS
     PQAPDPEEEE NRDSQQPGKR RKDSEEEAAS PEGKRVPKRL RCWEEEEDHE KERPEHKSLE
     SLADGGSASP IKDQPVMAVK TGEDGSNLDD AKGLAESLEL PKAIQDQLPR LQQLLKTLEE
     GLEGLEDAPP VELQLLHECS PSQMDLLCAQ LQLPQLSDLG LLRLCTWLLA LSPDLSLSNA
     TVLTRSLFLG RILSLTSSAS RLLTTALTSF CAKYTYPVCS ALLDPVLQAP GTGPAQTELL
     CCLVKMESLE PDAQVLMLGQ ILELPWKEET FLVLQSLLER QVEMTPEKFS VLMEKLCKKG
     LAATTSMAYA KLMLTVMTKY QANITETQRL GLAMALEPNT TFLRKSLKAA LKHLGP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024